FDA Slaps New Warnings On Testosterone Drugs
The U.S. Food and Drug Administration on Tuesday ordered AbbVie Inc., Eli Lilly & Co. and other manufacturers of testosterone replacement drugs to warn patients of serious cardiovascular risks and clarify...To view the full article, register now.
Already a subscriber? Click here to view full article